Mark F. Kubik
Corporate Officer/Principal at GENOR BIOPHARMA HOLDINGS LIMITED
Mark F. Kubik active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Corporate Officer/Principal | 16/08/2021 | - |
Career history of Mark F. Kubik
Former positions of Mark F. Kubik
| Companies | Position | Start | End |
|---|---|---|---|
OncoImmune, Inc.
 OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - | - |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/03/2021 | - |
Training of Mark F. Kubik
| University of Colorado Boulder | Undergraduate Degree |
| The Leeds School of Business | Masters Business Admin |
Statistics
International
| United States | 6 |
| China | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
OncoImmune, Inc.
OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD. | Health Technology |
- Stock Market
- Insiders
- Mark F. Kubik
- Experience
